BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2018 11:54:24 AM | Browse: 1410 | Download: 2217
 |
Received |
|
2018-04-24 02:32 |
|
Peer-Review Started |
|
2018-04-24 05:42 |
|
First Decision by Editorial Office Director |
|
2018-05-09 00:09 |
|
Return for Revision |
|
2018-05-14 01:35 |
|
Revised |
|
2018-05-16 15:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-06-07 12:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-06-08 04:31 |
|
Articles in Press |
|
2018-06-08 04:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-08-13 07:21 |
|
Publish the Manuscript Online |
|
2018-08-16 11:54 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jin-Zhi Wang, Hai-Xia Cao, Jian-Neng Chen and Qin Pan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key Research and Development Plan ‘Precision Medicine Research’ |
No. 2017YFC0908903 |
| National Natural Science Foundation of China |
81070346 |
| National Natural Science Foundation of China |
81270492 |
| National Natural Science Foundation of China |
81470859 |
| National Natural Science Foundation of China |
81270491 |
| National Natural Science Foundation of China |
81470840 |
| State Key Development Program for Basic Research of China |
No. 2012CB517501 |
| 100 Talents Program |
No. XBR2011007h |
| Program of the Committee of Science and Technology |
No. 09140903500 |
|
| Corresponding Author |
Qin Pan, MD, PhD, Professor, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Kongjiang Road NO 1665, Yangpu District, Shanghai 200092, China. panqin@xinhuamed.com.cn |
| Key Words |
Non-alcoholic fatty liver disease; Patatin-like phospholipase domain-containing protein 3; Treatment; Lifestyle; Pharmacotherapy; Surgery; Polymorphism |
| Core Tip |
Patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 imposes universal, yet distinctly different, impact on various therapies in nonalcoholic fatty liver disease (NAFLD) patients. As compared to those with C-allele, patients with PNPLA3 rs738409 G-allele (PNPLA3 148M variant) show grater improvement in response to lifestyle modification, dipeptidyl peptidase-4 inhibitor ingestion, and bariatric surgery. In contrast, NAFLD patients carrying PNPLA3 rs738409 C-allele (PNPLA3 148I variant) are much sensitive to both omega-3 poly-unsaturated fatty acids and statin intervention. These diversities in treatment response warrant a personalized, precise medicine in NAFLD by stratification of PNPLA3 rs738409 genotype. |
| Publish Date |
2018-08-16 11:54 |
| Citation |
Wang JZ, Cao HX, Chen JN, Pan Q. PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. World J Clin Cases 2018; 6(8): 167-175 |
| URL |
http://www.wjgnet.com/2307-8960/full/v6/i8/167.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v6.i8.167 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
